Jason Hsu, MD
Show Description +
Jason Hsu, MD, shares 18-month data from GATHER1, showing a nearly 28% reduction in GA growth with avacincaptad pegol compared with sham.
Posted: 10/21/2021
Jason Hsu, MD
Jason Hsu, MD, shares 18-month data from GATHER1, showing a nearly 28% reduction in GA growth with avacincaptad pegol compared with sham.
Posted: 10/21/2021
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2021.
Please log in to leave a comment.